Zydus Cadila is one of the leading investors in research and has a team of over 950 professionals spearheading its efforts in research at the Zydus Research Centre (ZRC), the dedicated research arm of the group. A team of over 350 research scientists dedicatedly work on New Molecular Entity (NME) research alone at ZRC. Making brisk progress in NME research, the group now has seven INDs in various stages of clinical trials and several more INDs in pre-clinical evaluation.
Located at Moraiya near the Group's corporate headquarters in Ahmedabad, Gujarat, ZRC is spread over 3,60,000 sq ft. ZRC also has the facility to conduct Bioequivalent studies, which is approved by ANVISA, Brazil
